Breaking News Instant updates and real-time market news.

AGN

Allergan

$227.55

-4.81 (-2.07%)

14:28
10/16/16
10/16
14:28
10/16/16
14:28

Allergan forms group to improve diagnosis, management of IBS

Allergan announced the formation of the IBS CounSEL, a group of multidisciplinary experts dedicated to improving diagnosis and management of irritable bowel syndrome by providing support to physicians and healthcare professionals. "The American Gastroenterological Association's recent 'IBS in America' survey found that when physicians were asked what is lacking most in the treatment of IBS, the second-most-common answer was communication between doctors and patients. With this in mind, Allergan looked to bring together healthcare professionals to develop practical tools and provide expert guidance for physicians," the company explained.

  • 26

    Oct

  • 02

    Nov

  • 06

    Nov

AGN Allergan
$227.55

-4.81 (-2.07%)

09/21/16
GABE
09/21/16
NO CHANGE
GABE
Buy
Gabelli questions if Allergan could target Gilead next
Gabelli analyst Kevin Kedra said that "like most" he was surprised at the price paid and the strategic fit of Allergan's (AGN) deal to buy Tobira Therapeutics (TBRA), but wonders if Allergan CEO Brent Saunders is "playing chess while the market is playing checkers" and could be preparing a bid for Gilead (GILD). After Allergan's "very loud statement about its commitment to NASH and liver disease," a deal for Gilead, the leading company in liver disease and "one of the cheapest companies in pharma/biotech," would appear to make more sense, Kedra tells investors, adding that an acquisition of Gilead at a price of $115 per share would be "highly accretive" for Allergan. The analyst keeps a Buy rating on Allergan shares.
09/22/16
BERN
09/22/16
NO CHANGE
BERN
Allergan acquisitions positive, says Bernstein
After Allergan bought two companies with NASH drugs and the stock fell, Bernstein analyst Aaron Gal says the acquisitions were viewed as expensive. Gal says "it makes almost no difference" if the deals were expensive, as the important issue is whether the products succeed. He believes that the market would never penalize Roche or Celgene for similar deals, and he thinks this indicates that Allergan is "misvalued." He says that Allergan is his "high conviction buy" stock and keeps a $335 price target on the shares.
09/26/16
LEER
09/26/16
NO CHANGE
LEER
Shire Xiidra launch to 'significantly' expand dry eye category, says Leerink
Leerink analyst Jason Gerberry remains optimistic that Shire's (SHPG) Xiidra launch will "significantly" expand the category for dry eye disease brands, while not meaningfully eroding Allergan's (AGN) Restasis market leading position. While it's still early in the launch of Xiidra and payer access remains a critical variable, the analyst does not anticipate access being a major barrier. Gerberry reiterates an Outperform rating on both Shire and Allergan's shares.
10/14/16
LEER
10/14/16
NO CHANGE
Target $294
LEER
Outperform
Leerink positive on Allergan ahead of Restasis patent decision
Leerink analyst Jason Gerberry is positive on Allergan's franchise outlook as he believes the company will either maintain a double-digit top-line" growth pharma" trajectory or alternatively institute a dividend, and will prevail in the ongoing Restasis patent challenge. Gerberry likes Allergan's underlying growth trends of the gastro and derm franchises and pipeline optionality, and reiterates an Outperform rating and $294 price target on the shares.

TODAY'S FREE FLY STORIES

ED

Consolidated Edison

$78.74

-0.535 (-0.67%)

14:45
01/18/18
01/18
14:45
01/18/18
14:45
Hot Stocks
Consolidated Edison boosts quarterly dividend to 71.5c per share »

Consolidated Edison…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBF

SoftBank

$84.00

-0.425 (-0.50%)

14:43
01/18/18
01/18
14:43
01/18/18
14:43
Periodicals
SoftBank closes $1.2B deal to invest in Uber, TechCrunch says »

SoftBank's $1.2B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FE

FirstEnergy

$29.73

-0.195 (-0.65%)

14:31
01/18/18
01/18
14:31
01/18/18
14:31
Conference/Events
FirstEnergy participates in a webcast with Wolfe Research »

Utilities Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

COG

Cabot Oil & Gas

$27.76

-0.225 (-0.80%)

14:30
01/18/18
01/18
14:30
01/18/18
14:30
Options
Notable call buying in Cabot Oil and Gas »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:30
01/18/18
01/18
14:30
01/18/18
14:30
General news
Canada manufacturing preview »

Canada manufacturing…

14:28
01/18/18
01/18
14:28
01/18/18
14:28
Conference/Events
Wolfe Research airlines/A&D analyst holds an analyst/industry conference call »

Airlines and Aerospace…

IIIN

Insteel

$29.83

0.57 (1.95%)

14:27
01/18/18
01/18
14:27
01/18/18
14:27
Downgrade
Insteel rating change  »

Insteel downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

URI

United Rentals

$181.44

1.27 (0.70%)

14:25
01/18/18
01/18
14:25
01/18/18
14:25
Options
United Rentals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

XLK

Technology Select Sector SPDR

$67.80

0.25 (0.37%)

, XLF

Financial Select Sector

$29.41

0.04 (0.14%)

14:17
01/18/18
01/18
14:17
01/18/18
14:17
Technical Analysis
Technical Take: S&P 500 turns positive, bullish intraday pattern active »

The S&P 500 (SPX) has…

XLK

Technology Select Sector SPDR

$67.80

0.25 (0.37%)

XLF

Financial Select Sector

$29.41

0.04 (0.14%)

XLE

Energy Select Sector SPDR

$76.83

-0.28 (-0.36%)

XLV

Health Care Select Sector SPDR

$87.91

-0.18 (-0.20%)

SPY

SPDR S&P 500 ETF Trust

$279.59

-0.02 (-0.01%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

14:17
01/18/18
01/18
14:17
01/18/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
01/18/18
01/18
14:16
01/18/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADT

ADT Inc.

, APO

Apollo Global

$35.12

-0.3 (-0.85%)

14:14
01/18/18
01/18
14:14
01/18/18
14:14
Syndicate
ADT Inc. IPO likely to price below $17-$19 range, WSJ reports »

ADT's (ADT) initial…

ADT

ADT Inc.

APO

Apollo Global

$35.12

-0.3 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 19

    Jan

FB

Facebook

$177.60

-0.79 (-0.44%)

, AXP

American Express

$100.17

-0.59 (-0.59%)

14:12
01/18/18
01/18
14:12
01/18/18
14:12
Hot Stocks
Facebook appoints American Expres CEO Chenault to board »

Facebook (FB) announced…

FB

Facebook

$177.60

-0.79 (-0.44%)

AXP

American Express

$100.17

-0.59 (-0.59%)

IBM

IBM

$169.03

0.38 (0.23%)

PG

Procter & Gamble

$90.28

-0.2304 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 23

    Jan

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 16

    Feb

  • 28

    Feb

TTWO

Take-Two

$116.09

2.13 (1.87%)

14:05
01/18/18
01/18
14:05
01/18/18
14:05
Options
TakeTwo Interactive Software call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

MGNX

MacroGenics

$19.85

0.07 (0.35%)

14:01
01/18/18
01/18
14:01
01/18/18
14:01
Hot Stocks
MacroGenics 'encouraged' by sudy of margetuximab plus pembrolizumab »

MacroGenics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

13:55
01/18/18
01/18
13:55
01/18/18
13:55
Conference/Events
House Homeland Security Committee to hold a hearing »

The Transportation and…

QEP

QEP Resources

$10.93

-0.04 (-0.36%)

13:55
01/18/18
01/18
13:55
01/18/18
13:55
Conference/Events
House Committee on Natural Resources to hold an oversight hearing »

The Subcommittee on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

JAGX

Jaguar Health

$0.14

0.002 (1.43%)

13:53
01/18/18
01/18
13:53
01/18/18
13:53
Conference/Events
Jaguar Health to hold a conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTCT

PTC Therapeutics

$21.95

0.46 (2.14%)

13:51
01/18/18
01/18
13:51
01/18/18
13:51
Periodicals
PTC raised price of muscular-dystrophy drug by 9%, WSJ reports »

PTC Therapeutics raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTX

Manitex

$9.63

0.11 (1.16%)

13:48
01/18/18
01/18
13:48
01/18/18
13:48
Hot Stocks
Manitex announces $6.3M order for cranes »

Manitex International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMNY

Helios and Matheson

$7.73

-0.43 (-5.27%)

13:45
01/18/18
01/18
13:45
01/18/18
13:45
Options
Helios and Matheson call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

13:41
01/18/18
01/18
13:41
01/18/18
13:41
Periodicals
Amazon sends team to Israel to determine market conditions, Globes reports »

Amazon sent a team to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 19

    Jan

  • 18

    Mar

DB

Deutsche Bank

$18.57

0.05 (0.27%)

13:33
01/18/18
01/18
13:33
01/18/18
13:33
Periodicals
Cryan says Deutsche Bank in 'third phase' of turnaround, Bloomberg reports »

Deutsche Bank CEO John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

FMC

FMC Corporation

$89.31

-4.55 (-4.85%)

, ALB

Albemarle

$117.89

-9.065 (-7.14%)

13:32
01/18/18
01/18
13:32
01/18/18
13:32
Hot Stocks
Lithium producers get crushed after Chile regulator rules on SQM »

Shares of lithium…

FMC

FMC Corporation

$89.31

-4.55 (-4.85%)

ALB

Albemarle

$117.89

-9.065 (-7.14%)

SQM

SQM

$58.29

-1.26 (-2.12%)

TSLA

Tesla

$347.16

7.1 (2.09%)

F

Ford

$12.09

-0.09 (-0.74%)

TM

Toyota

$138.70

-2.02 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 13

    Feb

  • 28

    Feb

  • 07

    Mar

SLB

Schlumberger

$77.02

-0.195 (-0.25%)

13:31
01/18/18
01/18
13:31
01/18/18
13:31
Technical Analysis
Technical Earnings Preview: Schlumberger has a potential bullish pattern »

On the 1-year daily…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.